Advanced Development through Licensure of a Hemorrhagic Fever Virus Therapeutic

Award Notice Posted

Solicitation number
W9113M-09-R-0008
Agency
Awarded
Set-aside
No set-aside

Opportunity facts

Contract number
W9113M-C-0056
NAICS code
541711 Research and Development in Biotechnology
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

This contract action was not awarded as a fixed price type because uncertainties involved in contract performance did not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost-reimbursement type action was awarded (FAR 16.301-2).

Advanced Development through Licensure of a Hemorrhagic Fever Virus Therapeutic

Update #1 ·

This contract action was not awarded as a fixed price type because uncertainties involved in contract performance did not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost-reimbursement type action was awarded (FAR 16.301-2).

Advanced Development through Licensure of Hemorrhagic Fever Virus Therapeutics, Ebola and Marburg

Notice history

Notice Type Posted
This notice Latest Award Notice
Development of Medical Countermeasure (Therapeutics) for the Treatment of Hemorrhagic Fever Viruses (HFV) Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors